Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup.

Authors

Susan E Waisbren
Shawn E Christ
Deborah A Bilder
Kendra J Bjoraker
Scout Bolton
Sarah Chamberlin
Mitzie Grant, Tower Health Medical Group, St. Christopher's Hospital for Children, and Drexel College of Medicine, Philadelphia, PA, United States of AmericaFollow
Darren M Janzen
Rachel Katz
Eugene Lubliner
Arianna Martin
Kelsey McQueen
Olga Moshkovich
Mina Nguyen-Driver
Soo Shim
Arianna K Stefanatos
Greta Wilkening
Cary Harding

Document Type

Article

Publication Date

7-25-2024

Publication Title

Molecular genetics and metabolism

Volume

143

Issue

1-2

First Page

108555

Last Page

108555

Comments

online ahead of print

Recommended Citation

Waisbren, S., Christ, S., Bilder, D., Bjoraker, K., Bolton, S., Chamberlin, S., Grant, M., Janzen, D., Katz, R., Lubliner, E., Martin, A., McQueen, K., Moshkovich, O., Nguyen-Driver, M., Shim, S., Stefanatos, A., Wilkening, G., & Harding, C. (2024). Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup.. Molecular genetics and metabolism, 143 (1-2), 108555-108555. https://doi.org/https://doi.org/10.1016/j.ymgme.2024.108555